Mental illness and mental health: Is the glass half empty or half full?

Canadian Journal of Psychiatry

Volumn 57, Issue 11, 2012, Pages 651-658

  Pierre, Joseph M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjustment disorder; Bereavement; Contextual utility; Diagnostic expansion; Mental health; Mental illness; Neuroenhancement; Prevalence inflation

Indexed keywords

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; MENTAL DISEASE; MENTAL HEALTH; PSYCHOSOMATICS; REVIEW;

EID: 84873038517     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371205701102     Document Type: Review

References (104)

1. Menninger K. The vital balance: the life process in mental health and illness. New York (NY): Viking; 1963.
2. Compton WM, Guze SB. The neo-Kraepelinian revolution in psychiatric diagnosis. Eur Arch Psychiatry Clin Neurosci. 1995;245:196-201.
3. Grob GN. Origins of DSM-I: a study in appearance and reality. Am J Psychiatry. 1991;148:421-431.
4. Grob GN. The forging of mental health policy in America: World War II to new frontier. J Hist Med Allied Sci. 1987;42(4):410-446.
5. Decker HS. How Kraepelinian was Kraepelin? How Kraepelinian are the neo-Kraepelinians?-from Emil Kraepelin to DSM-III. Hist Psychiatry. 2007;18(3):337-360.
6. Ghaemi SN. Nosologomania: DSM & Karl Jaspers' critique of Kraepelin. Phil Ethics Humanit Med. 2009;4:10.
7. Shorter E. A history of psychiatry: from the era of the asylum to the age of Prozac. New York (NY): John Wiley & Sons, Inc; 1997.
8. Horwitz A. Creating mental illness. Chicago (IL): The University of Chicago Press; 2002.
9. Double DB. What would Adolf Meyer have thought of the neo- Kraepelinian approach? Psychiatr Bull. 1990;14:472-474.
10. Meyer A. The mental hygiene movement. Can Med Assoc J. 1918;8(7):632-634.
11. Cohen S. The mental hygiene movement, the development of personality and the school: the medicalization of American education. Hist Educ Q. 1983;23(2):123-149.
12. The Committee on Nomenclature and Statistics of the American Psychiatric Association. Diagnostic and statistical manual: mental disorders. Washington (DC): American Psychiatric Association; 1952.
13. Klerman GL. The evolution of a scientific nosology. In: Sherstow JC, editor. Schizophrenia: science and practice. Cambridge (MA): Harvard University Press; 1978.
14. Feighner JP, Robins E, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972;26:57-63.
15. Spitzer RL, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry. 1978;35:773-782.
16. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970;126:983-987.
17. Wilson M. DSM-III and the transformation of American psychiatry: a history. Am J Psychiatry. 1993;150:399-410.
18. Spitzer RL, Williams JBW. American psychiatry's transformation following the publication of DSM- III. Am J Psychiatry. 1994;151(3):459-460.
19. Stein DJ, Philips KS, Bolton D, et al. What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med. 2010;40:1759-1765.
20. First MB, Wakefield JC. Defining 'mental disorder' in DSM-IV. Psychol Med. 2010;40:1779-1782.
21. Broome M, Bortolotti L. What's wrong with 'mental' disorders? Psychol Med. 2010;40:1783-1785.
22. Verhoeff B, Glas G. The search for dysfunctions. Psychol Med. 2010;40:1787-1788.
23. Pierre JM. The borders of mental illness in psychiatry and the DSM: past, present, and future. J Psychiatr Pract. 2010;16(6):375-386.
24. Double D. The limits of psychiatry. BMJ. 2002;324:900-904.
25. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62:593-602.
26. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2005;62:617-627.
27. Moffitt TE, Caspie A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010;40:899-909.
28. Smith R. In search of "non-disease". BMJ. 2002;324:883-885.
29. Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: an experiential approach to behavioral change. New York (NY): Guilford Press; 1999.
30. Horwitz AV, Wakefield JC. The loss of sadness: how psychiatry transformed normal sorrow into depressive disorder. Oxford (GB): Oxford University Press; 2007.
31. Wakefield JC. Diagnosing DSM-IV-Part 1: DSM-IV and the concept of disorder. Behav Res Ther. 1997;35(7):633-649.
32. Wakefield JC. The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry. 2007;6:149-156.
33. McNally RJ. On Wakefield's dysfunction analysis of mental disorder. Behav Res Ther. 2001;39:309-314.
34. Pies RW. Depression and the pitfalls of causality: implications for DSM-V. J Affect Disord. 2009;116(1-2):1-3.
35. Varga S. Defining mental disorder: exploring the 'natural function' approach. Phil Ethics Humanit Med. 2011;6:1. Also available from: http://www.peh-med.com/content/6/1/1.
36. Wakefield JC, Schmitz MF, First MB. Extending the bereavement exclusion for major depression to other losses: evidence from the National Comorbidity Survey. Arch Gen Psychiatry. 2007;64:433-440.
37. Zisook S, Kendler KS. Is bereavement-related depression different from non-bereavment related depression? Psychol Med. 2007;37:779-794.
38. Frances A. How to avoid medicalizing normal grief in DSM5 [Internet]. Psychiatric Times. 2010 Mar 16 [cited 2011 Oct 20]. Available from: http://www.psychiatrictimes.com/topics/content/article/10168/1538825.
39. Zisook S, Shuchter SR, Pedrelli P, et al. Bupropion sustained release for bereavement: results of an open trial. J Clin Psychiatry. 2001;62:227-230.
40. Hensley PL, Slonimski CK, Uhlenhuth EH, et al. Escitalopram: an open-label study of bereavement-related depression and grief. J Affect Disord. 2009;113(1-2):142-149.
41. Zisook S, Simon NM, Reynolds CF, et al. Bereavement, complicated grief, and DSM, part 2: complicated bereavement. J Clin Psychiatry. 2010;71(8):1097-1098.
42. Lichtenthal WG, Cruess DG, Prigerson HG. A case for establishing complicated grief as a distinct mental disorder in DSM-V. Clin Psychol Rev. 2004;24:637-662.
43. Shear MK, Sinmon NM, Wall M, et al. Complicated grief and related bereavement issues of DSM-5. Depress Anxiety. 2011;28:103-117.
44. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA; 1994.
45. Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: does it help solve the false positive problem? Am J Psychiatry. 1999;156:1856-1864.
46. Baumeister H, Kufner K. It is time to adjust the adjustment disorder category? Curr Opin Psychiatry. 2009;22:409-412.
47. Strain JJ, Diefenbacher A. The adjustment disorders: the conundrums of diagnosis. Compr Psychiatry. 2008;49:121-130.
48. Maercker A, Einsle F, Kollner V. Adjustment disorders as stress response syndromes: a new diagnostic concept and its exploration in a medical sample. Psychopathology. 2007;40:135-146.
49. Baumeister H, Maercker A, Casey P. Adjustment disorder with depressed mood: a critique of its DSM-IV and ICD-10 conceptualisations and recommendations for the future. Psychopathology. 2009;42:139-147.
50. Strain JJ, Friedman MJ. Considering adjustment disorders as stress response syndromes for DSM-5. Depress Anxiety. 2011;28(9):818-823.
51. Charney DS. Psychobiologic mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry. 2004;161:195-216.
52. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci. 2009;10:446-457.
53. Davydov DM, Stewart R, Ritchie K, et al. Resilience and mental health. Clin Psychol Rev. 2010;30:479-495.
54. Lamb K, Pies R, Zisook S. The bereavement exclusion for the diagnosis of major depression: to be, or not to be. Psychiatry. 2010;7(7):19-25.
55. American Psychiatric Association (APA). Proposed draft revisions to DSM disorders and criteria: G 04 adjustment disorders [Internet]. Arlington (VA): APA; 2012 [updated 2012 Apr 30; cited 2011 Oct 20]. Available from: http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=367.
56. The President's New Freedom Commission on Mental Health. Achieving the promise: transforming mental health care in America. Final report [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2003 Jul [cited 2011 Oct 20]. Available from: http://store.samhsa.gov/shin/content// SMA03-3831/SMA03-3831.pdf. Executive summary. Vision statement.
57. Wikipedia contributors. It's the economy, stupid [Internet]. Wikipedia, The Free Encyclopedia; 2012 Aug 14, 17:23 UTC [cited 2011 Oct 20]. Available from: http://en.wikipedia.org/wiki/It%27s-the-economy,-stupid. James Carville was a campaign strategist in Bill Clinton's 1992 presidential campaign.
58. Haslam N. Psychiatric categories as natural kinds: essentialist thinking about mental disorder. Soc Res. 2000;67(4):1031-1058.
59. Kendler KS. An historical framework for psychiatric nosology. Psychol Med. 2009;39:1935-1941.
60. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4-12.
61. Jablensky A. Boundaries of mental disorders. Curr Opin Psychiatry. 2005;18:653-658.
62. Pierre JM. Deconstructing schizophrenia for DSM-5: challenges for clinical and research agendas. Clin Schizophr Relat Psychoses. 2008;2:166-174.
63. First MB, Pincus HA, Levine JB, et al. Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry. 2004;161:946-954.
64. Zimmerman M, Galione J. Psychiatrists' and nonpsychiatrist physicians' reported use of the DSM-IV criteria for major depressive disorder. J Clin Psychiatry. 2010;71:235-238.
65. Magruder KM, Calderone GE. Public health consequences of different thresholds for the diagnosis of mental disorders. Compr Psychiatry. 2000;41(2 Suppl 1):14-18.
66. Kessler RC, Merikangas KR, Berglind P, et al. Mild disorders should not be eliminated from the DSM-5. Arch Gen Psychiatry. 2003;60:1117-1122.
67. Farah MJ, Illes J, Cook-Deegan R, et al. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci. 2004;5:421-425.
68. Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456:702-705.
69. Larriviere D, Williams MA, Rizzo M, et al. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology. 2009;73:1406-1412.
70. Henry M, Fishman JR, Younger SJ. Propranolol and the prevention of post-traumatic stress disorder: is it wrong to erase the "sting" of bad memories? Am J Bioethics. 2007;7:12-20.
71. Cakic V. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. J Med Ethics. 2009;35:611-615.
72. Goodman R. Cognitive enhancement, cheating, and accomplishment. Kennedy Inst Ethics J. 2010;20(2):145-160.
73. Kass LR, chairman. Beyond therapy: biotechnology and the pursuit of happiness. A report of The President's Council on Bioethics [Internet]. Washington (DC): Bioethics Research Library, Georgetown University; 2003 Oct [cited 2011 May 1]. Available from: http://bioethics.georgetown.edu/pcbe/ reports/beyondtherapy/beyond-therapy-final-webcorrected.pdf.
74. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ. 2002;324(7342):886-891.
75. Healy D. The latest mania: selling bipolar disorder. PLoS Med. 2006;3:e185.
76. Zimmerman M. Why are we rushing to publish DSM-IV? Arch Gen Psychiatry. 1988;45:1135-1138.
77. Pierre JM. Mental disorder vs normality: defining the indefinable. Bull Assoc Adv Philos Psychiatry. 2010;17:9-11.
78. Bland RC, Newman SC, Orn H. Help-seeking for psychiatric disorders. Can J Psychiatry. 1997;42(9):935-942.
79. Bergeron E, Poirer LR, Fournier L, et al. Determinants of service use among young Canadians with mental disorders. Can J Psychiatry. 2005;50(10):629-636.
80. Saint Arnault D. Cultural determinants of help seeking: a model of research and practice. Res Theory Nurs Pract. 2009;23(4):259-278.
81. Aoun S, Pennebaker D, Wood C. Assessing population need for mental health care: a review of approaches and predictors. Ment Health Serv Res. 2004;6(1):33-46.
82. Demyttenaere K, Bruffaerts R, Posada-Villa J, et al, [WHO World Mental Health Survey Consortium]. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291:2581-2590.
83. Kovess-Masfety V, Saragoussi D, Sevilla-Dedieu C, et al. What makes people decide who turn to when faced with a mental health problem? Results from a French survey. BMC Public Health. 2007;7:188.
84. Regier DA, Kaelber CT, Tae DS, et al. Limitations of diagnostic criteria and assessment instruments for mental disorders: implications for research and policy. Arch Gen Psychiatry. 1998;5:109-115.
85. Goldman HH, Grob GN. Defining 'mental illness' in mental health policy. Health Aff (Millwood). 2006;25(3):737-749.
86. Substance Abuse and Mental Health Services Administration. Final notice establishing definitions for (1) children with a serious emotional disturbance, and (2) adults with a serious mental illness. Fed Regist. 1993;58:29422-29425.
87. Ustun B, Kennedy C. What is "functional impairment"? Disentangling disability from clinical significance. World Psychiatry. 2009;8:82-85.
88. Casey P. Adjustment disorder: epidemiology, diagnosis and treatment. CNS Drugs. 2009;23(11):927-938.
89. Angermeyer MC, Matschinger H, Riedel-Heller SG. Whom to ask for help in case of a mental disorder? Preferences of the lay public. Soc Psychiatry Psychiatr Epidemiol. 1999;34(4):202-210.
90. Casey P. Adult adjustment disorder: a review of its current diagnostic status. J Psychiatr Pract. 2001;7:32-40.
91. Frisman LK, Rosenheck R. The impact of disability payments on persons with addictive disorders. Psychiatr Ann. 2002;32(5):303-307.
92. Pierre JM, Wirshing DA, Wirshing WC. 'Iatrogenic malingering' in VA substance abuse treatment. Psychiatr Serv. 2003;54:253-254.
93. Frey WD, Azrin ST, Goldman HH, et al. The Mental Health Treatment Study. Psychiatr Rehabil J. 2008;31(4):306-312.
94. Leo RJ. Social Security disability and the mentally ill: changes in the adjudication process and treating source information requirements. Psychiatr Ann. 2002;32(5):284-292.
95. Sartre JP. No exit and three other plays. New York (NY): Alfred A Knopf; 1989. Quotation from the play The Flies.
96. Helmchen H, Linden M. Subthreshold disorders in psychiatry: clinical reality, methodologic artifact, and the double-threshold problem. Compr Psychiatry. 2000;41(2 Suppl 1):1-7.
97. Freud S, Breuer J. Studies in hysteria. Luckhurst N, translator. New York (NY): Penguin Group; 2004.
98. McMahon DM. Happiness: a history. New York (NY): Atlantic Monthly Press; 2006.
99. Mojtabai R. Americans' attitudes towards psychiatric medications: 1998-2006. Psychiatr Serv. 2009;60:1015-1023.
100. Pagura J, Katz LY, Mojtabai R, et al. Antidepressant use in the absence of common mental disorders in the general population. J Clin Psychiatry. 2011;72(4):494-501.
101. Khan A, Leventhal RM, Khan SR, et al. Severity of depression and response to antidepressants and placebo: an analysis of the food and drug administration database. J Clin Psychopharmacol. 2002;22:40-45.
102. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
103. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level metaanalysis. JAMA. 2010;303:46-53.
104. Regier DA, Narrow WE, Kuhl EA, et al. The conceptual development of DSM-5. Am J Psychiatry. 2009;166:645-650.